Jianwei Zheng

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis”.

S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis

Chemico-Biological Interactions(2020)10.1016/j.cbi.2020.108965

N/A

0DataRank · unranked

29 citations

Jianwei Zheng, June X. Zou, Jianzhen Xu, Fanghai Han, Songtao Xiang +4 more

Trends in heart failure costs for commercially insured patients in the United States (2006–2021)

BMC Health Services Research(2024)10.1186/s12913-024-11240-4

N/A

0DataRank · unranked

5 citations

Islam Abudayyeh, Cyril Rakovski, Louis Ehwerhemuepha, Ahmad Rezaie Mianroodi, Jay Patel +3 more